VEGFA and neoplasm: Considering of single tumors within each group revealed that 3 of 10 tumors in the anti-VEGF/chemotherapy group, 6 out of 10 tumors in the CrossMab group and 10 out of 10 tumors in the CrossMab/chemotherapy group had shown complete growth retardations with tumor stasis in different volume stages until completion of the study.